Facet Biotech Corporation - Product Pipeline Review - Q4 2010

Date: November 1, 2010
Pages: 40
Price:
US$ 500.00
License [?]:
Publisher: Global Markets Direct
Report type: Company Report
Delivery: E-mail Delivery (PDF)
ID: F6154B042F8EN
Leaflet:

Download PDF Leaflet

Facet Biotech Corporation - Product Pipeline Review - Q4 2010
Summary

Global Market Direct’s pharmaceuticals report, “Facet Biotech Corporation - Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects. It also gives a complete picture of the company’s future therapy areas of focus.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.

Scope

- Facet Biotech Corporation - company overview including business description, key employees, and other facts.
- Review of current pipeline of Facet Biotech Corporation human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of Facet Biotech Corporation with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of the Facet Biotech Corporation’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Facet Biotech Corporation’s strategic position with total access to a detailed intelligence on its product pipeline.
- Assess the growth potential of Facet Biotech Corporation in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Facet Biotech Corporation’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Facet Biotech Corporation.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Facet Biotech Corporation and identify potential opportunities in those areas.
- Do deals with an understanding of the mergers and partnerships that have shaped the sector.
1 TABLE OF CONTENTS

1.1 List of Tables
1.2 list of Figures

2 INTRODUCTION
3 FACET BIOTECH CORPORATION SNAPSHOT

3.1 Business Description

4 FACET BIOTECH CORPORATION- RESEARCH AND DEVELOPMENT OVERVIEW

4.1 Key Therapeutic Areas

5 FACET BIOTECH CORPORATION- PIPELINE REVIEW

5.1 Pipeline Products by Stage of Development
5.2 Pipeline Products-Monotherapy
5.3 Pipeline Products-Combination Treatment Modalities

6 FACET BIOTECH CORPORATION PIPELINE PRODUCTS GLANCE

6.1 Facet Biotech Corporation Phase II Pipeline
6.2 Facet Biotech Corporation Phase I Pipeline
6.3 Facet Biotech Corporation Pre-Clinical Pipeline

7 FACET BIOTECH CORPORATION - DRUG PROFILES

7.1 Product
  7.1.1 Product Description
  7.1.2 Mechanism of Action
  7.1.3 R&D Progress

8 FACET BIOTECH CORPORATION PIPELINE ANALYSIS

8.1 Facet Biotech Corporation Pipeline Products by Therapeutic Class
8.2 Facet Biotech Corporation Pipeline Products by Target
8.3 Facet Biotech Corporation Pipeline by Route of Administration
8.4 Facet Biotech Corporation Pipeline Products by Molecule Type

9 FACET BIOTECH CORPORATION- RECENT PIPELINE UPDATES
10 FACET BIOTECH CORPORATION- DORMANT PIPELINE PROJECTS

10.1 Feature on Dormant Projects

11 FACET BIOTECH CORPORATION- DISCONTINUED PIPELINE PRODUCTS

11.1 Discontinued Pipeline Product Profiles
  11.1.1 Product

12 FACET BIOTECH CORPORATION – FEATURED NEWS
13 FACET BIOTECH CORPORATION STATEMENT

13.1 Facet Biotech Corporation - Locations and Subsidiaries

14 APPENDIX

14.1 Global Markets Direct Research Methodology
14.2 Coverage
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Expert Panels
14.7 Contact Us
14.8 Disclaimer

LIST OF TABLES

Table 1: Facet Biotech Corporation - Key Information
Table 2: Facet Biotech Corporation - Key Facts
Table 3: Facet Biotech Corporation - Key Therapeutic Areas
Table 4: Facet Biotech Corporation - Pipeline by Stage of Development,
Table 5: Facet Biotech Corporation - Monotherapy Products in Pipeline,
Table 6: Facet Biotech Corporation - Combination Treatment Modalities in Pipeline,
Table 7: Facet Biotech Corporation - Phase II Pipeline,
Table 8: Facet Biotech Corporation - Phase I Pipeline,
Table 9: Facet Biotech Corporation - Pre-Clinical Pipeline,
Table 10: Facet Biotech Corporation - Pipeline By Therapeutic Class
Table 11: Facet Biotech Corporation - Pipeline By Target
Table 12: Facet Biotech Corporation - Pipeline By Route of Administration
Table 13: Facet Biotech Corporation - Pipeline By Molecule Type
Table 14: Facet Biotech Corporation - Recent Pipeline Updates
Table 15: Facet Biotech Corporation - Dormant Pipeline Projects

LIST OF FIGURES

Figure 1: Facet Biotech Corporation - Research and Development Overview
Figure 2: Facet Biotech Corporation - Pipeline by Stage of Development,
Figure 3: Facet Biotech Corporation - Monotherapy Products in Pipeline,
Figure 4: Facet Biotech Corporation - Combination Treatment Modalities in Pipeline,
Figure 5: Facet Biotech Corporation - Pipeline By Therapeutic Class and Stage of Development
Figure 6: Facet Biotech Corporation - Pipeline By Therapeutic Class
Figure 7: Facet Biotech Corporation - Pipeline By Target and Stage of Development
Figure 8: Facet Biotech Corporation - Pipeline By Target
Figure 9: Facet Biotech Corporation - Pipeline By Route of Administration and Stage of Development
Figure 10: Facet Biotech Corporation - Pipeline By Route of Administration
Figure 11: Facet Biotech Corporation - Pipeline By Molecule Type and Stage of Development
Figure 12: Facet Biotech Corporation - Pipeline By Molecule Type

COMPANIES MENTIONED

Facet Biotech Corporation

Ask Your Question

Facet Biotech Corporation - Product Pipeline Review - Q4 2010
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry: